Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

USANA HEALTH SCIENCES, INC.

(USNA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/16/2021 09/17/2021 09/20/2021 09/21/2021 09/22/2021 Date
87.46(c) 88.92(c) 88.05(c) 87.4(c) 88.41 Last
64 397 242 458 88 133 94 443 60 919 Volume
-0.06% +1.67% -0.98% -0.74% +1.16% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 1 193 M - -
Net income 2021 121 M - -
Net Debt 2021 - - -
P/E ratio 2021 14,7x
Yield 2021 -
Sales 2022 1 207 M - -
Net income 2022 120 M - -
Net Debt 2022 - - -
P/E ratio 2022 14,0x
Yield 2022 -
Capitalization 1 749 M 1 749 M -
Capi. / Sales 2021 1,47x
Capi. / Sales 2022 1,45x
Nbr of Employees 1 943
Free-Float 60,0%
More Financials
Company
USANA Health Sciences, Inc. develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia. Its product lines include USANA Nutritionals Essentials, Optimizers, Foods, Sense-beautiful science and All... 
Sector
Food Processing
Calendar
10/26Earnings Release
More about the company
Ratings of USANA Health Sciences, Inc.
Trading Rating :  -
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about USANA HEALTH SCIENCES, INC.
08:09aUSANA HEALTH SCIENCES : Yin Yang You, a global collaboration 5,000 years in the making
PR
09/16USANA HEALTH SCIENCES : Scales Back 2021 Revenue, Earnings Outlook -- Shares Drop 5% After..
MT
09/16GUIDANCE : (USNA) USANA HEALTH SCIENCES Sees Q3 Revenue Range $265M - $270M
MT
09/16USANA HEALTH SCIENCES : Provides Preliminary Third Quarter Results and Updates Fiscal Year..
PU
09/16USANA HEALTH SCIENCES INC : Regulation FD Disclosure (form 8-K)
AQ
09/16USANA HEALTH SCIENCES : Provides Preliminary Third Quarter Results and Updates Fiscal Year..
BU
09/16USANA Health Sciences, Inc. Provides Earnings Guidance for the Third Quarter of 2021
CI
09/16USANA Health Sciences, Inc. Revises Earnings Guidance for the Full Year 2021
CI
09/16USANA Health Sciences, Inc. announces an Increase in Equity Buyback.
CI
09/15USANA : joint-support supplement earns third seal of approval
PR
08/31USANA HEALTH SCIENCES : 10 Ways to Build Resilience for September's Self-Improvement Month
PR
08/31USANA HEALTH SCIENCES : 10 Ways to Build Resilience for September's Self-Improvement Month
AQ
08/18USANA HEALTH SCIENCES : IR Presentation Q2 2021
PU
08/18USANA : Releases 2020 Sustainability Report
PR
08/16USANA : CEO sets goal of 30,000 garden towers donated in the next year to provide long-ter..
PR
More news
News in other languages on USANA HEALTH SCIENCES, INC.
09/17MÄRKTE USA/Wall Street am Verfalltag mit leichten Abgaben
09/17MÄRKTE USA/Wall Street am Verfalltag vor leichten Verlusten
09/16USANA Health Sciences revoit à la baisse ses prévisions de revenus et de bénéfices pour..
09/16GUIDANCE : (USNA) USANA HEALTH SCIENCES prévoit une fourchette de revenus de 265 à 270 mil..
09/16USANA Health Sciences, Inc. fournit des prévisions de résultats pour le troisième trime..
More news
Analyst Recommendations on USANA HEALTH SCIENCES, INC.
More recommendations
Chart USANA HEALTH SCIENCES, INC.
Duration : Period :
USANA Health Sciences, Inc. Technical Analysis Chart | USNA | US90328M1071 | MarketScreener
Technical analysis trends USANA HEALTH SCIENCES, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Last Close Price 87,40 $
Average target price 90,00 $
Spread / Average Target 2,97%
EPS Revisions
Managers and Directors
Kevin G. Guest Chairman & Chief Executive Officer
Jim Brown President
G. Douglas Hekking Chief Financial Officer
Myron W. Wentz Chairman-Emeritus
Robert Andrew Sinnott Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
USANA HEALTH SCIENCES, INC.13.36%1 749
BY-HEALTH CO., LTD.5.96%6 868
HERBALIFE NUTRITION LTD.-8.16%4 660
BALCHEM CORPORATION22.05%4 552
THE SIMPLY GOOD FOODS COMPANY11.32%3 344
MEDIFAST, INC.10.31%2 504